DefiLlama relisted Aster data yesterday.
Foresight News reported that, according to the official website, DefiLlama has relaunched Aster data as of yesterday. Data shows that Aster's 24-hour contract trading volume is $16.18 billions, and the 7-day contract trading volume is $76.65 billions.
According to previous Foresight News reports, DefiLlama founder 0xngmi clarified the removal of Aster data, stating, "Platform users trust DefiLlama's data and make investment decisions based on it. If incorrect data is reported, they will make wrong decisions. DefiLlama has never taken money or received compensation for listing or delisting anything. Personally, I have never held any position (long or short) in HYPE or ASTER. The removal of Aster was due to a significant increase in trading volume over the past few days, which prompted more in-depth research. After the team conducted an investigation, action was taken. DefiLlama has also previously delisted other perpetual contract DEXs, and our only concern is the integrity of the data."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
